Ra Medical Systems CEO resigns

2023-04-19
高管变更
The resignation will take effect on April 28. He will also resign from his position on the board of directors of the electrophysiology procedures tech company. Ra Medical’s board of directors has established a committee for examining a transition at the CEO level. David Jenkins, executive chair of the board, will serve as interim CEO until a full-time replacement is named. McGuire has served at CEO of the company since April 2020. Prior to joining Ra MedicalRa Medical, he was president and CEO of Second Sight Medical. He has also held numerous leadership roles in the medtech industry at Covidien, AtheroMed, Guidant and Spectranetics. Earlier this year, Ra Medical completed a merger with Catheter Precision. As part of the deal, the combined company realigned its board of directors. Jenkins joined the board as executive chair, and James Caruso was appointed as a director. Martin Colombatto, McGuire and Susann Meline were appointed as directors. Additionally, directors Joan Stafslien and Richard Mejia resigned.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。